215 related articles for article (PubMed ID: 11964172)
1. Differential effect of the inhibition of Grb2-SH3 interactions in platelet activation induced by thrombin and by Fc receptor engagement.
Saci A; Liu WQ; Vidal M; Garbay C; Rendu F; Bachelot-Loza C
Biochem J; 2002 May; 363(Pt 3):717-25. PubMed ID: 11964172
[TBL] [Abstract][Full Text] [Related]
2. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
[TBL] [Abstract][Full Text] [Related]
3. A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity.
Cussac D; Vidal M; Leprince C; Liu WQ; Cornille F; Tiraboschi G; Roques BP; Garbay C
FASEB J; 1999 Jan; 13(1):31-8. PubMed ID: 9872927
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
Li S; Couvillon AD; Brasher BB; Van Etten RA
EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
[TBL] [Abstract][Full Text] [Related]
5. Independent binding of peptide ligands to the SH2 and SH3 domains of Grb2.
Lemmon MA; Ladbury JE; Mandiyan V; Zhou M; Schlessinger J
J Biol Chem; 1994 Dec; 269(50):31653-8. PubMed ID: 7527391
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of Ras signal transduction as antitumor agents.
Garbay C; Liu WQ; Vidal M; Roques BP
Biochem Pharmacol; 2000 Oct; 60(8):1165-9. PubMed ID: 11007954
[TBL] [Abstract][Full Text] [Related]
7. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL
J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Grb2-binding proteins in human platelets activated by Fc gamma RIIA cross-linking.
Robinson A; Gibbins J; Rodríguez-Liñares B; Finan PM; Wilson L; Kellie S; Findell P; Watson SP
Blood; 1996 Jul; 88(2):522-30. PubMed ID: 8695800
[TBL] [Abstract][Full Text] [Related]
9. Tight association of GRB2 with receptor protein-tyrosine phosphatase alpha is mediated by the SH2 and C-terminal SH3 domains.
den Hertog J; Hunter T
EMBO J; 1996 Jun; 15(12):3016-27. PubMed ID: 8670803
[TBL] [Abstract][Full Text] [Related]
10. Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homology 3 (SH3) domain-mediated association with Grb2.
Charest A; Wagner J; Kwan M; Tremblay ML
Oncogene; 1997 Apr; 14(14):1643-51. PubMed ID: 9135065
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
Tanaka M; Gupta R; Mayer BJ
Mol Cell Biol; 1995 Dec; 15(12):6829-37. PubMed ID: 8524249
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
13. The signal transduction through Grb2/Ash in hematopoietic cells.
Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
[TBL] [Abstract][Full Text] [Related]
14. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
15. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions.
Simon JA; Schreiber SL
Chem Biol; 1995 Jan; 2(1):53-60. PubMed ID: 9383403
[TBL] [Abstract][Full Text] [Related]
16. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2.
Xu XX; Yi T; Tang B; Lambeth JD
Oncogene; 1998 Mar; 16(12):1561-9. PubMed ID: 9569023
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.
Sharma PM; Son HS; Ugi S; Ricketts W; Olefsky JM
Mol Endocrinol; 2005 Feb; 19(2):421-30. PubMed ID: 15486046
[TBL] [Abstract][Full Text] [Related]
18. CBL-GRB2 interaction in myeloid immunoreceptor tyrosine activation motif signaling.
Park RK; Kyono WT; Liu Y; Durden DL
J Immunol; 1998 May; 160(10):5018-27. PubMed ID: 9590251
[TBL] [Abstract][Full Text] [Related]
19. Peptide LSARLAF induces integrin β3 dependent outside-in signaling in platelets.
Niu H; Xu Z; Li D; Zhang L; Wang K; Taylor DB; Liu J; Gartner TK
Thromb Res; 2012 Aug; 130(2):203-9. PubMed ID: 22482832
[TBL] [Abstract][Full Text] [Related]
20. Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling.
Najib S; Sánchez-Margalet V
J Cell Biochem; 2002; 86(1):99-106. PubMed ID: 12112020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
